ストックスクリーナーアプリを入手
5.28
3.53%
0.18
アフターアワーズ：
5.25
-0.03
-0.57%
Absci Corp (ABSI) 最新ニュース
CRISPR Therapeutics Has Major Catalysts Ahead. Is This Biotech Stock a Screaming Buy? - AOL.com
The 1 AI Stock I'd Put in a Time Capsule and Open in 2036 - AOL.com
Grail's Slump Enters Week 10. Is There Any End in Sight? - AOL.com
Doximity Stock Just Got Crushed. Is This a Rare Chance to Buy a High-Quality Growth Company on Sale? - AOL.com
JonesTrading Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $11 - Moomoo
2 Stocks That Could Realistically Double by 2030 - AOL.com
ABSI Price Today: Absci Corporation Stock Price, Quote & Chart | MEXC - MEXC Exchange
Absci Insider Buyers Pleased With US$700k Return On Investment - Yahoo Finance
AI-driven drug developer Absci lines up Jefferies and Goldman talks - Stock Titan
Portland InnoAbsci's move into generative AI | Why former Hydro Flask CEO joined Puffin - The Business Journals
Morgan Stanley Trims Price Target on Absci to $4.10 From $4.20, Keeps Equalweight Rating - Moomoo
AMD Reveals A $6.5 Million Marvell Bet That's Already Soaring - Sahm
Insider Buying: Menelas Pangalos Acquires Shares in Absci Corp (ABSI) - GuruFocus
Absci Corp (ABSI) director Menelas Pangalos adds 37,453 shares in open-market buy - Stock Titan
AMD Reveals A $6.5 Million Marvell Bet That's Already Soaring - Benzinga
HC Wainwright Has Optimistic Outlook of Absci Q3 Earnings - MarketBeat
Absci price target raised to $11 from $9 at JonesResearch - TipRanks
TradingKey - TradingKey
JonesTrading Maintains Absci Corp(ABSI.US) With Buy Rating, Raises Target Price to $11 - 富途牛牛
Earnings call transcript: Absci Corp misses revenue forecast in Q1 2026 - Investing.com UK
H.C. Wainwright Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $8 - Moomoo
Absci Corporation (ABSI) reports Q1 loss, misses revenue estimates - MSN
Absci Corp. Charts High-Stakes Path With ABS-201 - TipRanks
Needham Reiterates Buy Rating on ABSI with Price Target of $7.00 - GuruFocus
Needham Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $7 - Moomoo
Absci (NASDAQ:ABSI) Given New $11.00 Price Target at Truist Financial - MarketBeat
Absci’s ABS-201 Hair-Loss Trial Moves Forward: What Early-Stage Data Could Mean for ABSI - TipRanks
Absci (NASDAQ:ABSI) Shares Gap DownShould You Sell? - MarketBeat
Absci Shares Fall After 1Q Loss Widens - Moomoo
Truist Financial Maintains Absci Corp(ABSI.US) With Buy Rating, Announces Target Price $11 - 富途牛牛
Absci Corporation (NASDAQ:ABSI) Q1 2026 Earnings Call Transcript - Insider Monkey
12 Health Care Stocks Moving In Friday's Pre-Market SessionAbsci (NASDAQ:ABSI), Amylyx Pharmaceuticals - Benzinga
Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results - The Manila Times
TD Cowen Maintains Absci Corp(ABSI.US) With Buy Rating - 富途牛牛
Absci (NASDAQ:ABSI) Releases Quarterly Earnings Results, Hits Estimates - MarketBeat
Absci reports Q1 EPS (19c), consensus (20c) - TipRanks
Earnings call transcript: Absci’s Q1 2026 revenue falls short, stock dips - Investing.com Nigeria
Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Earnings call transcript: Absci’s Q1 2026 revenue falls short, stock dips By Investing.com - Investing.com South Africa
Absci Corp (NASDAQ:ABSI) Plunges on 86% Q1 Revenue Miss Despite Clinical Advances - ChartMill
Absci Q1 Earnings Call Highlights - Yahoo Finance
Hair-loss drug trial reaches patient dosing; Absci adds ABS-202 - Stock Titan
Absci (ABSI) posts Q1 2026 results, advances ABS-201 and adds ABS-202 - Stock Titan
Absci (NASDAQ: ABSI) Q1 loss widens as revenue falls to $0.2M - Stock Titan
Absci : Corporate Presentation, May 2026 - marketscreener.com
Absci (ABSI) Q1 2026 Earnings Call Transcript - The Globe and Mail
0.98%
0.12%
大文字化:
|
ボリューム (24 時間):